Compound Radar

GoodRx Holdings, Inc. (GDRX) Stock Analysis

Price $3.52
Market cap $1.20B
Next earnings Nov 3, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

59
59/100 Acceptable
  • Financial Health 40
  • Profitability 65
  • Business Quality 75
  • Balance Sheet 55
  • Cash Flow 70

Why this rating?

Health 59/100 — Acceptable

Strongest Business Quality 75/100
Softest Financial Health 40/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

GoodRx Holdings, Inc. (GDRX) is a Health Information Services company in the Healthcare sector. Compound Radar rates GoodRx Holdings, Inc. 59/100 (Acceptable) due to high business quality, manageable leverage, and attractive valuation.

Investment profile

  • Quality High
  • Growth Soft
  • Balance Sheet Adequate
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 58.67
  • Forward P/E 9.88
  • EV/Revenue 1.82

Profitability

  • Revenue Growth -1.3%
  • Gross Margin 90.8%
  • Operating Margin 11.8%
  • Net Margin 2.1%
  • ROE 2.5%

Financial strength

  • Cash $296.11M
  • Debt $538.95M
  • Net Cash $-242.84M
  • Free Cash Flow $93.88M
  • Current Ratio 1.38

Similar companies

Peers in Health Information Services, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Health Information Services →

FAQ

How Compound Radar scores and tracks GoodRx Holdings, Inc. (GDRX).

View Methodology & FAQ →